Table 1

Description of apps targeting individuals living with and beyond cancer available on Apple’s App Store and Google Play

Cancer types coveredNo (N) (all apps, n=151 n (%)Unique to Apple
n=47,
N (%)
Unique to Google n=38
N (%)
All cancers89 (58.9)23 (48.9)24 (63.2)
Breast22 (14.6)9 (19.1)5 (13.2)
Prostate9 (6.0)5 (10.6)2 (5.3)
Lung or mesothelioma5 (3.3)2 (4.3)2 (5.2)
Bladder or renal5 (3.3)3 (6.4)1 (2.6)
Liver and/or pancreas3 (2.0)3 (6.4)0 (0.0)
Haematological3 (2.0)0 (0.0)1 (2.6)
Retinoblastoma, eye or childhood cancers3 (2.0)0 (0.0)1 (2.6)
Colorectal2 (1.3)0 (0.0)0 (0.0)
Melanoma2 (1.3)1 (2.1)0 (0.0)
Multiple cancers (breast and ovarian, breast, prostate and colorectal)2 (1.3)0 (0.0)0 (0.0)
Head and neck or oral2 (1.3)1 (2.1)1 (2.6)
Others (testicular, ovarian, soft-tissue sarcoma, carcinoid)4 (2.6)0 (0.0)1 (2.6)
Type of developer
 Commercial or private organisation65 (43.0)23 (48.9)20 (52.6)
 Charity or non-profit organisation30 (19.9)12 (25.5)1 (2.6)
 Unclear16 (10.6)2 (4.3)11 (28.9)
 Healthcare organisation15 (9.9)7 (14.9)3 (7.9)
 Academic organisation8 (5.3)2 (4.3)2 (5.3)
 Clinical or research societies/networks or government4 (2.7)0 (0.0)0 (0.0)
 Partnership of various types of organisation13 (8.6)1 (2.1)1 (2.6)
Country of origin
 USA68 (45.0)25 (53.2)5 (13.2)
 Unclear31 (20.5)7 (14.9)17 (44.8)
 UK, Ireland or Gibraltar15 (9.9)8 (17.0)1 (2.6)
 Multinational7 (4.6)2 (4.3)1 (2.6)
 India7 (4.6)0 (0.0)5 (13.2)
 Canada5 (3.3)0 (0.0)2 (5.3)
 Malaysia or Singapore5 (3.3)1 (2.1)3 (7.9)
 Australia4 (2.6)2 (4.3)0 (0.0)
 The Netherlands3 (2.0)1 (2.1)1 (2.6)
 Others (France, Germany, Hungary, Morocco, Pacific Islands, Spain)6 (4.0)1 (2.1)3 (7.9)
No of downloads (Google Play data only for 104 apps)
 <10045 (43.3)17 (44.7)
 100–50024 (23.1)10 (26.3)
 500–10009 (8.7)4 (10.5)
 1000–500017 (16.3)4 (10.5)
 5000–10 0003 (2.9)1 (2.6)
 10 000–50 0005 (4.9)2 (5.3)
 >50 0001 (0.9)0 (0.0
Price to download (£ Sterling)
 Free140 (92.7)46 (97.9)34 (89.5)
 <£9.49 Google Play/<£12.99 App store9 (6.0)1 (2.1)2 (5.3)
 >£12.992 (1.3)02 (5.3)